Furosemide inhalation in dyspnea of mustard gas-exposed patients: A triple-blind randomized study

Inhalation Toxicology

Volumn 20, Issue 9, 2008, Pages 873-877

  Panahi, Yunes ^a   Motiei Langroudi, Rouzbeh ^a   Alaeddini, Farshid ^a   Naghizadeh, Mohammad Mehdi ^a   Aslani, Jafar ^a   Ghanei, Mostafa ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; MUSTARD GAS;

ADULT; AGED; ARTICLE; BRONCHIOLITIS; CHRONIC BRONCHITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DYSPNEA; FORCED EXPIRATORY VOLUME; HUMAN; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIPLE BLIND PROCEDURE; VISUAL ANALOG SCALE; VITAL CAPACITY;

ADMINISTRATION, INHALATION; ADULT; AGED; AGED, 80 AND OVER; CHEMICAL WARFARE AGENTS; CROSS-OVER STUDIES; DIURETICS; DOUBLE-BLIND METHOD; DYSPNEA; FORCED EXPIRATORY VOLUME; FUROSEMIDE; HUMANS; INHALATION EXPOSURE; MIDDLE AGED; MUSTARD GAS; RESEARCH DESIGN; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 47749147290     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958370701861520     Document Type: Article

References (41)

1. Adams, L., Chronos, N., Lane, R. and Guz, A. 1985 The measurement of breathlessness induced in normal subjects: Validity in two scaling techniques. Clin. Sci. 69:7-16.
2. Aghanouri, R., Ghanei, M., Aslani, J., Keivani-Amine, H., Rastegar, F., and Karkhane, A. 2004. Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to SM. Am. J. Physiol. Lung Cell. Mol. Physiol. 287:1160-1164.
3. Anderson, S. D., Wei, H. E., and Temple, D. M. 1991. Inhibition by furosemide of inflammatory mediators from lung fragments. N. Engl. J. Med. 324:131.
4. Barnes, P. J. 1993. Diuretics and asthma. Thorax 48:195-196.
5. Beheshti, J., Mark, E. J., Akbari, H. M. H., Aslani, J., and Ghanei, M. 2006. Mustard lung secrets: Long term clinicopathologic study following mustard gas exposure. Pathology Res. Pract. 202:739-744.
6. Bianco, S., Pieroni, M. G., Refini, R. M., Rattoli, L., and Sestini, P. 1989. Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions. N. Engl. J. Med. 321:1069-1073.
7. Bianco, S., Vaghi, A., Robushi, M.,and Pasargiklian, M. 1988. Prevention of exerciseinduced bronchoconstriction by inhaled furosemide. Lancet 2:252-255.
8. Brooks, S. M. 1982. Task group on surveillance for respiratory hazards in the occupational setting. Surveillance for respiratory hazards. ATS News 8:12-16.
9. Cavaliere, F., and Masieri, S. 2002. Furosemide protective effect against airway obstruction. Curr. Drug Targets 3:197-201.
10. Chung, K. F., and Barnes, P. J. 1994. Loop diuretics and asthma. Pulmon. Pharmacol. 5:1-7.
11. Corboz, M. R., Ballard, S. T., Inglis, S. K., and Taylor, A. E. 1997. Dilatory effect of furosemide on rat tracheal arterioles and venules. Am. J. Respir. Crit. Care Med. 156:478-483.
12. Dompeling, E., Jöbsis, Q., Vandevijver, N. M. A., Wesseling, G., and Hendriks, H. 2004. Chronic bronchiolitis in a 5-yr-old child after exposure to sulphur mustard gas. Eur. Respir. J. 23:343-346.
13. Emad, A., and Rezaian, G. R. 1997. The diversity of effects of sulphur mustard gas inhalation on respiratory system 10 years after a single heavy exposure: Analysis of 197 cases. Chest 112:734-738.
14. Fabbri, L., Pauwels, R. A., and Hard, S. S. 2004. GOLD scientific committee. Global strategy for the diagnosis, management and prevention of COPD: GOLD executive summary updated 2003. COPD 1:105-141.
15. Freed, A. N., Taskar, V., Schofield, B., and Omori, L. 1996. Effect of furosemide on hyperpnea-induced airway obstruction, injury, and microvascular leakage. J. Appl. Physiol. 81:2461-2467.
16. Ghanei, M., and Amini Harandi, A. 2007. Long term consequences from exposure to sulfur mustard: A review. Inhal. Toxicol. 19:451-456.
17. Ghanei, M., Mokhtari, M., Mohammad, M. M., and Aslani, J. 2004. Bronchiolitis obliterans following exposure to sulfur mustard: Chest high resolution computed tomography. Eur. J. Radiol. 52:164-169.
18. Ghanei, M., Shohrati, M., Harandi, A.A., Eshraghi, M., Aslani, J., Alaeddini, F., and Manzoori, H. 2007. Inhaled corticosteroids and long-acting beta 2-agonists in treatment of patients with chronic bronchiolitis following exposure to sulfur mustard. Inhal Toxicol. 19:889-894.
19. Gilbert, I. A., Lenner, K. A., Nelson, J. A., Wolin, A. D., and Fonke, J.M. 1994. Inhaled furosemide attenuates hyperpnea-induced obstruction and intra-airway thermal gradients. J. Appl. Physiol. 76:409-415.
20. Gonzalez-Sanchez, R., Trujillo-Hernandez, B., Huerta, M., Vasquez, C., and Trujillo, X. 2002. Furosemide plus albuterol compared with albuterol alone in children with acute asthma. Allergy Asthma Proc. 23:181-184.
21. Hasham, F., Kennedy, J. D., and Jones, R. S. 1981. Actions of salbutamol, disodium cromoglycate, and placebo administered as aerosols in acute asthma. Arch. Dis. Child. 56:722-725
22. Hinckley, J. B. 2000. Inhaled furosemide in the treatment of acute exacerbations of asthma. Acad. Emerg. Med. 7:1167.
23. Karpel, J. P., Dworkin, F., Hager, D., Feliciano, S., Shapiro, D., Posner, L., and Luks, D. 1994. Inhaled furosemide is not effective in acute asthma. Chest 106:1396-1400.
24. Knox, A. J., and Ajao, P. 1990. Effect of frusemide on airway smooth muscle contractility in vitro. Thorax 45:856-859.
25. Liss, H. P., and Grant, B. J. B. 1988. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 137:1285-1288.
26. Müller, N. L., and Miller, R. R. 1995. Diseases of the bronchioles: CT and histopathologic findings. Radiology 196:3-12.
27. Nishino, T., Ide, T., Sudo, T., and Sato, J. 2000. Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea. Am. J. Respir. Crit. Care Med. 161:1963-1967.
28. Noseda, A., Carpiaux, J. P., Markstein, C., Meyvaert, A., and Maertelaer, V. 1997. Disabling dyspnoea in patients with advanced disease: Lack of effect of nebulized morphine. Eur. Respir. J. 10:1079-1083.
29. Noseda, A., Schmerber, J., Prigogine, T., and Yernault, J. C. 1992. Perceived effect on shortness of breath of an acute inhalation of saline or terbutaline: Variability and sensitivity of a visual analogue scale in patients with asthma or COPD. Eur. Respir. J. 5:1043-1053.
30. Ong, K. C., Kor, A. C., Chong, W. F., Earnest, A., and Wang, Y. T. 2004. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 169:1028-1033.
31. Ono, Y., Kondo, T., Tanigaki, T., and Ohta, Y. 1997. Furosemide given by inhalation ameliorates acute exacerbation of asthma. J. Asthma 34:283-289.
32. Pendino, J. C., Nannini, L. J., Chapman, K. R., Slutsky, A., and Molfino, N. A. 1998. Effect of inhaled furosemide in acute asthma. J. Asthma 35:89-93.
33. Robuschi, M., Gambaro, G., Spagnotto, S., Vaghi, A., and Bianco, S. 1987. Inhaled furosemide is highly effective in preventing ultrasonically nebulised water bronchoconstriction. Pulmon. Pharmacol. 1:187-191.
34. Rodriguez Vazquez, J. C., Pino Alfonso, P. P., Gassiot Nuno, C., Paez Prats, I., and Fernandez Manzano, E. 1998. Assessment of the bronchodilator effect of inhaled furosemide compared to salbutamol in asthmatic patients. J. Invest. Allergol. Clin. Immunol. 8:115-118.
35. Schwartzstein, R. M., Lahive, K., Pope, A., Weinberger, S. E., and Weiss, J. W. 1987. Cold facial stimulation reduces breathlessness induced in normal subjects. Am. Rev. Respir. Dis. 136:58-61.
36. Solway, J., and Leff, A. R. 1991. Sensory neuropeptides and airway function. J. Appl. Physiol. 71:2077-2087.
37. Tanigaki, T., Kondo, T., Hayashi, Y., Katoh, H., Kamio, K., Urano, T., and Ohta, Y. 1997. Rapid response to inhaled frusemide in severe acute asthma with hypercapnia. Respiration 64:108-110.
38. Thomason, J. W., Rice, T. W., and Milstone, A. P. 2003. Bronchiolitis obliterans in a survivor of a chemical weapons attack. J. Am. Med. Assoc. 290:598-599.
39. Van Bever, H. P., Desager, K. N., Pauwels, J. H., Wojciechowski, M., and Vermeire, P. A. 1995.Aerosolized furosemide in wheezy infants: A negative report. Pediatr. Pulmonol. 20:16-20.
40. Ventresca, P. G., Nichol, G. M., Barnes, P. J., and Chung, K. F. 1990. Inhaled furosemide inhibits cough induced by low-chloride solutions but not by capsaicin. Am. Rev. Respir. Dis. 142:143-146.
41. Zoorob, R. J., and Campbell, J. S. 2003. Acute dyspnea in the office. Am. Family Physician 68:1803-1810.